The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

Share Price Information for Phoenix Group Holdings (PHNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 511.00
Bid: 510.50
Ask: 511.00
Change: 6.50 (1.29%)
Spread: 0.50 (0.098%)
Open: 505.50
High: 513.50
Low: 504.50
Prev. Close: 504.50
PHNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Indicative Result of Tender Offer

5 Dec 2023 10:22

RNS Number : 7322V
Phoenix Group Holdings PLC
05 December 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION TO ANY U.S. PERSON (as defined in regulation s under THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) ("U.S. PERSON") OR IN OR INTO THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (THE "UNITED STATES") OR in or into ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

5 December 2023

Phoenix Group Holdings plc announces Indicative Results of Offers

Phoenix Group Holdings plc (the "Company") announces today the indicative results of its invitations made to eligible holders (the "Noteholders") of its outstanding £428,113,000 6.625 per cent. Subordinated Notes due 2025 (ISIN: XS1171593293) (the "Sterling Notes") and/or its U.S.$500,000,000 Fixed Rate Reset Tier 2 Notes due 2031 (ISIN: XS2182954797) (the "U.S.$ Notes" and, together with the Sterling Notes, the "Notes"), as described in the tender offer memorandum dated 27 November 2023 (the "Tender Offer Memorandum") (each such invitation an "Offer" and together the "Offers").

Capitalised terms used but not otherwise defined in this announcement shall have the meanings given to them in the Tender Offer Memorandum.

The Expiration Deadline for the Offers was 16:00 (London time) on 4 December 2023. Settlement is expected to take place on 7 December 2023.

The Company hereby announces, on a non-binding and indicative basis only, that it will accept for purchase in accordance with the terms and subject to the conditions (including the satisfaction or waiver of the Financing Condition) set out in the Tender Offer Memorandum, validly tendered Notes for purchase pursuant to the Offers, in an aggregate principal amount of approximately £350,000,000 (equivalent). The Company further announces, on a non-binding and indicative basis only, the aggregate principal amount of each Series accepted for purchase (each a "Series Acceptance Amount") is expected to be as set out in the table below.

Description

ISIN/Common Code

Outstanding Principal Amount

Indicative Series Acceptance Amount

Indicative Scaling Factor (Priority Tendered Notes)*

Indicative Scaling Factor (Non-Priority Tendered Notes)*

£428,113,000 6.625 per cent. Subordinated Notes due 2025

XS1171593293/117159329

£428,113,000

£230,949,000

None applied

67.7999%

U.S.$500,000,000 Fixed Rate Reset Tier 2 Notes due 2031

XS2182954797/218295479

U.S.$500,000,000

U.S.$150,000,000

None applied

43.7367%

*In line with the approach specified in the Tender Offer Memorandum, where Tender and Priority Acceptance Instructions related to a greater principal amount of Notes (on an aggregate basis taking into account tenders for such Noteholder of both the Sterling Notes and the U.S.$ Notes) than the principal amount of New Notes (converted in whole or in part into U.S.$ at the U.S.$ FX Rate and rounded down to the nearest U.S.$1,000, if applicable) it subscribed for and was allocated, the Company has, in its sole discretion, deemed the relevant Tender and Priority Acceptance Instruction or Tender and Priority Acceptance Instructions to be (A) Tender and Priority Acceptance Instruction(s) for only the principal amount of Notes in respect of which the relevant Noteholder has obtained Priority Acceptance and (B) Tender Only Instruction(s) for the additional Notes the relevant Noteholder wishes to tender for purchase in excess of such Priority Acceptance Amount, applying such approach to a Noteholder(s) Tender Instructions in a manner that is determined in the Company's sole discretion.

Pricing for the Offer for the Sterling Notes will take place at or around 11.00 a.m. (London time) today (the "Pricing Time").

The Company will announce the final results of the Offers as soon as reasonably practicable after the Pricing Time. Such announcement will specify whether the Company will accept (subject to satisfaction or waiver of the Financing Condition) valid tenders of Notes for purchase pursuant to either or both the Offers and, if so accepted, (i) the Benchmark Security Rate, the Purchase Yield and the Purchase Price for the Sterling Notes accepted for purchase (if applicable), (ii) the Series Acceptance Amount in respect of each Series; and (iii) details of any pro rata scaling in respect of each Series.

Subject to the satisfaction (or wavier) of the Financing Condition, the Settlement Date for the Offers which is expected to be 7 December 2023.

Any requests for information in relation to the Offers should be directed to the Dealer Managers or the Tender Agent whose contact details are: Banco Bilbao Vizcaya Argentaria, S.A. at 44th Floor, One Canada Square, London E14 5AA, United Kingdom, Attention: Liability Management, or by telephone at +44 207 397 6029 and +44 207 397 6061 or email liabilitymanagement@bbva.com; HSBC Bank plc at 8 Canada Square, London E14 5HQ, United Kingdom, Attention: Liability Management, DCM, or by telephone at +44 20 7992 6237 or email LM_EMEA@hsbc.com; J.P. Morgan Securities plc at 25 Bank Street, Canary Wharf, London E14 5JP, United Kingdom, Attention: EMEA Liability Management Group, or by telephone at +44 20 7134 2468 or email liability_management_EMEA@jpmorgan.com; Merrill Lynch International at 2 King Edward Street, London EC1A 1HQ, United Kingdom, Attention: Liability Management Group, or by telephone at +44 20 7996 5420 or email DG.LM-EMEA@bofa.com; NatWest Markets Plc at 250 Bishopsgate, London EC2M 4AA, United Kingdom, Attention: Liability Management, or by telephone at +44 20 7678 5222 or email NWMliabilitymanagement@natwestmarkets.com; and Kroll Issuer Services Limited at The Shard, 32 London Bridge Street, London SE1 9SG, United Kingdom, Attention: Jacek Kusion, or by telephone at +44 20 7704 0880 or email phoenix@is.kroll.com.

REGULATORY INFORMATION AND DISCLAIMER

This announcement contains information that qualified or may have qualified as inside information within the meaning of Article 7(1) of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended, the "EUWA").

The person responsible for arranging release of this announcement on behalf of the Company is Kulbinder Dosanjh, Group Company Secretary. The Legal Entity Identifier of the Offeror is: 2138001P49OLAEU33T68.

This announcement must be read in conjunction with the Tender Offer Memorandum. This announcement and the Tender Offer Memorandum contain important information which should be read carefully before any decision is made with respect to the Offers. If any Noteholder is in any doubt as to the contents of this announcement, the Tender Offer Memorandum or the action it should take, it is recommended to seek its own financial, legal, regulatory and any other advice, including in respect of any financial, accounting, regulatory and tax consequences, immediately from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser.

The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum comes are required by each of the Company, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RTENKPBBKBDDDBK
Date   Source Headline
9th Oct 201912:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20192:45 pmRNSDirector/PDMR Shareholding
30th Sep 201912:15 pmRNSTotal Voting Rights
9th Sep 20194:15 pmRNSDirector/PDMR Shareholding
30th Aug 20191:15 pmRNSTotal Voting Rights
27th Aug 201911:10 amRNSHolding(s) in Company
16th Aug 201910:30 amRNSBlock Listing Application
15th Aug 20193:30 pmRNSPublication of Suppl.Prospcts
12th Aug 20193:00 pmRNSDirector/PDMR Shareholding
7th Aug 20193:00 pmRNSDirector/PDMR Shareholding
7th Aug 20197:00 amRNS2019 Half-Year Results
31st Jul 20193:00 pmRNSTotal Voting Rights
18th Jul 20195:12 pmRNSDirectorate Change
10th Jul 20199:00 amRNSDirector/PDMR Shareholding
5th Jul 20193:00 pmRNSDirector/PDMR Shareholding
28th Jun 201912:45 pmRNSTotal Voting Rights
28th Jun 201910:00 amRNSDirectorate Change
27th Jun 20194:00 pmRNSDirector/PDMR Shareholding
24th Jun 201911:30 amRNSPublication of a Prospectus
20th Jun 20195:15 pmRNSBlock listing Interim Review
20th Jun 20195:15 pmRNSDirector/PDMR Shareholding
18th Jun 20199:45 amRNSPGH PLC Issuer of Senior Debt Securities Update
13th Jun 20191:00 pmRNSDirector/PDMR Shareholding
10th Jun 201910:15 amRNSDirector/PDMR Shareholding
6th Jun 20194:00 pmRNSDirector/PDMR Shareholding
28th May 20192:00 pmRNSDirector/PDMR Shareholding
16th May 20193:30 pmRNSHolding(s) in Company
8th May 20193:45 pmRNSDirector/PDMR Shareholding
8th May 20193:45 pmRNSDirector/PDMR Shareholding
2nd May 201912:15 pmRNSResult of AGM
1st May 20192:00 pmRNSDirector/PDMR Shareholding
17th Apr 20193:00 pmRNSDirector/PDMR Shareholding
10th Apr 20198:00 amRNSDirector/PDMR Shareholding
8th Apr 20192:30 pmRNSHolding(s) in Company
3rd Apr 20192:00 pmRNSHolding(s) in Company
2nd Apr 20193:30 pmRNSDirector/PDMR Shareholding
29th Mar 20194:15 pmRNSDirector/PDMR Shareholding
29th Mar 20192:00 pmRNSDirector/PDMR Shareholding
29th Mar 20192:00 pmRNSTotal Voting Rights
26th Mar 20194:00 pmRNSDirector/PDMR Shareholding
26th Mar 20194:00 pmRNSDirector Declaration
26th Mar 20194:00 pmRNSHolding(s) in Company
22nd Mar 20195:20 pmRNSNotice of AGM
22nd Mar 20194:30 pmRNSHolding(s) in Company
22nd Mar 20194:30 pmRNSDirector/PDMR Shareholding
14th Mar 20193:00 pmRNSDirector/PDMR Shareholding
14th Mar 20193:00 pmRNSDirector/PDMR Shareholding
6th Mar 20195:00 pmRNSDirector/PDMR Shareholding
5th Mar 20197:00 amRNS2018 Full Year Results
28th Feb 20192:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.